Advertisement

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

Romanos Sklavenitis-Pistofidis, Marzia Capelletti, Chia-Jen Liu, Mairead Reidy, Oksana Zavidij, Daisy Huynh, Patrick Henrick, Alexandra Savell, Kaitlen Reyes, Bradley Rivotto, Mark Bustoros, Adriana Perilla-Glen, Lorenzo Trippa, Jorge J. Castillo, Steven P. Treon and Irene M. Ghobrial

Article Information

Citation 
vol. 132 no. 24 2608-2612
PubMed 

Print ISSN 
Online ISSN 
History 
  • Published online December 13, 2018.

Article Versions


Contributors 
  • Romanos Sklavenitis-Pistofidis, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Marzia Capelletti, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Chia-Jen Liu, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Mairead Reidy, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Oksana Zavidij, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Daisy Huynh, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Patrick Henrick, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Alexandra Savell, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Kaitlen Reyes, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Bradley Rivotto, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Mark Bustoros, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Adriana Perilla-Glen, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Lorenzo Trippa, 2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
  • Jorge J. Castillo, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Steven P. Treon, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Irene M. Ghobrial, 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output